|
|
Feature |
Comment |
Present in αlpha? |
|
1 |
Proven scientific reliability |
Should be based on peer-reviewed published
data and statistical methodology |

|
|
2 |
Down's syndrome risk estimation method |
Must be capable of interpreting tests based
on maternal age and NT, PAPP-A, hCG and nasal bone presence or absence in the first trimester and AFP, uE3,
hCG and inhibin in the second trimester |
 |
|
3 |
Transparency |
Interpretation and risk estimation should be
capable of independent verification using specified data and methods
Statistical parameters used should be
available in the software and supporting documentation.
|
 |
|
4 |
Normal medians of screening markers |
Should allow the used of laboratory-specific
normal medians to derive MoM values.
Should not update medians automatically;
the user should maintain control |
 |
|
5 |
Result interpretation |
Provide screening interpretations based on
all test protocols, including first trimester combined test, second
trimester quadruple test, the Integrated test and sequential testing.
Should divide results into screen-positive
and screen-negative categories, according to pre-assigned risk cut-off.
|
 |
|
6 |
Adjusting MoMs |
Should provide facility to adjust for:
- Maternal weight
- Method of estimating gestational age
- Ethnic group
- Insulin dependent diabetes mellitus
- Smoking
- MoM values in previous pregnancies
- Twin pregnancy
- In vitro fertilization
|
 |
|
7 |
Adjusting risk estimates |
Should adjust for:
- Previous history of Down's syndrome or
open neural tube defects
- Previous screening result in same
pregnancy (repeat testing)
|
 |
|
8 |
Nuchal translucency |
Should allow:
- Use of user derived NT median values
- Facilities for monitoring (median MoM,
standard deviation and % increase in MoM values with gestation) and
updating sonographer and site specific NT medians
|
 |
|
9 |
Monitoring facilities |
Should allow over specified calendar
periods, the monitoring of:
- Number of patients screened
- Screen positive rate
- Numbers updated or corrected
- Normal medians to allow the
identification and correction of any drift
- Age distribution of screened
population
- Expected detection and false-positive
rates based on age distribution for any combination of screening
markers
|
 |
|
10 |
Validation of risk estimation |
Should provide facility to allow pregnancy
outcomes to be entered and to confirm that the Down's syndrome risk
calculated agrees with the observed
prevalence
|
 |
|
11 |
Database |
Should allow for:
- Exporting of results into other
software for further analysis
- Audit trail for screening policy and
individual patient reports
|
 |
|
12 |
Support |
Should provide:
- Comprehensive on site installation and
training
- Readily available professional
technical support
|
 |
|
13 |
Latest scientific advances |
Should provide regular free software upgrades to ensure
users have access to the latest screening methods
|
 |